Výsledky vyhledávání

Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study

Autor: Dhiraj Abhyankar, Milind Gole, Preeti Raut, Ashish Shedage

Publikováno v: Therapeutic Delivery. 7:545-551

Background: Cyclizine is used in the treatment and prevention of nausea and vomiting. We aimed to demonstrate bioequivalence between two formulations of cyclizine 50 mg tablets. Methods/Results: This single-dose, two-treatment, two-period, two-sequen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76f15c4876a03444c01fc7bfba074539
https://doi.org/10.4155/tde-2016-0023

Zobrazit plný text záznamu

Pharmacokinetics of fixed-dose combination of tenofovir disoproxil fumarate, lamivudine, and efavirenz: results of a randomized, crossover, bioequivalence study

Autor: Dhiraj Abhyankar, Ashish Shedage, Preeti Raut, Milind Gole

Publikováno v: International Journal of STD & AIDS. 28:491-498

The objective of this study was to assess the bioequivalence between a fixed-dose combination of tenofovir disoproxil fumarate/lamivudine/efavirenz 300/300/600 mg and the individual innovator products. A randomized, balanced, open-label, two-sequence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8541a080fccc3b128ee59a1bc7e912e
https://doi.org/10.1177/0956462416655955

Zobrazit plný text záznamu

Comparison of Pharmacokinetics of Two Fenofibrate Tablet Formulations in Healthy Human Subjects

Autor: Siddharth Chachad, Raghu Naidu, Geena Malhotra, Milind Gole

Publikováno v: Clinical Therapeutics. 36:967-973

Background Fenofibrate is a serum lipid-lowering agent used as an adjunct to diet in patients with hypercholesterolemia and hypertriglyceridemia. The new fenofibrate tablet formulation was developed as a pharmaceutical equivalent to the marketed tabl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82382cc57b487396cbd2b6186c9d6b44
https://doi.org/10.1016/j.clinthera.2014.04.017

Zobrazit plný text záznamu

Comparative Steady State Cross-Over Bioequivalence Study of 35mg Trimetazidine Extended-Release Tablets

Autor: Ashish Shedage, Geena Malhotra, are, Shrinivas Pur, Milind Gole, Abhishek Khanna

Publikováno v: Journal of Bioequivalence & Bioavailability.

Background: Trimetazidine (TMZ), an anti-ischemic drug, protects the myocardial cell from the harmful effects of ischemia. This study is aimed to determine bioequivalence between the test (Trimetazidine ER Tablet of Cipla Limited, India) and the refe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::826d68a36acb718208f3ce67b47dad8c
https://doi.org/10.4172/jbb.1000203

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání